A61P 11/04
Drugs for disorders of the respiratory system: for throat disorders
Official title: for throat disorders
A61P11/04 (Drugs for disorders of the respiratory system: for throat disorders) appears on 847 US grants and 1,356 published applications in this corpus.
Search patents in A61P- Granted patents
- 847
- Published applications
- 1,356
- Assignees
- 608
- Inventors
- 2,564
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 11 | 0 |
| 1999 | 6 | 0 |
| 2000 | 11 | 0 |
| 2001 | 16 | 2 |
| 2002 | 11 | 12 |
| 2003 | 6 | 37 |
| 2004 | 12 | 49 |
| 2005 | 8 | 42 |
| 2006 | 14 | 45 |
| 2007 | 24 | 59 |
| 2008 | 21 | 70 |
| 2009 | 34 | 68 |
| 2010 | 27 | 120 |
| 2011 | 36 | 88 |
| 2012 | 49 | 103 |
| 2013 | 77 | 82 |
| 2014 | 68 | 68 |
| 2015 | 62 | 75 |
| 2016 | 54 | 64 |
| 2017 | 40 | 68 |
| 2018 | 51 | 75 |
| 2019 | 49 | 42 |
| 2020 | 49 | 58 |
| 2021 | 31 | 34 |
| 2022 | 28 | 26 |
| 2023 | 16 | 26 |
| 2024 | 13 | 22 |
| 2025 | 6 | 9 |
| 2026 | 7 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cyclopentenyl purine derivative or salt thereof18 Aug 2026US 12,709,629 B2FUJIFILM Corporation
- Methods of preparing anti-human papillomavirus antigen T cells11 Aug 2026US 12,702,706 B2The United States of America, as represented by the Secretary, Department of Health and Human Seervices
- Recombinant interferon with changed spatial configuration26 May 2026US 12,636,347 B2
- Bifidobacterium longum31 Mar 2026US 12,589,124 B2PrecisionBiotics Group Limited
- Jellyfish collagen use24 Feb 2026US 12,558,402 B2Jellagen Pty Ltd
- Composition comprising recombinant clostridium neurotoxin20 Aug 2026US 2026/0240963 A1Ipsen Bioinnovation Limited
- Preparation Method for and Use of Dihydrothienopyrimidine Derivative20 Aug 2026US 2026/0242393 A1Innovstone Therapeutics Limited
- Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy13 Aug 2026US 2026/0232793 A1Memorial Sloan Kettering Cancer Center
- Methods and compositions for treating sleep apnea23 Jul 2026US 2026/0207698 A1Apnimed, Inc. (Delaware)
- Orally administered corticosteroid compositions26 Mar 2026US 2026/0083668 A1Ellodi Pharmaceuticals, L.P.
Most cited
By later US patents
- Methods for using tetanus toxin for beneficial purposes in animals (mammals)171US 7,494,661 B22009
- Morphinan compounds151US 7,973,049 B2Concert Pharmaceuticals, Inc. · 2011
- Morphinan compounds142US 8,188,110 B2Concert Pharmaceuticals, Inc. · 2012
- Morphinan compounds140US 8,541,436 B2Concert Pharmaceuticals, Inc. · 2013
- Otorhinological delivery device124US 7,294,345 B2Schering Corporation · 2007